Endocrine, Metabolic & Immune Disorders - Drug Targets

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Back Subscribe
Research Article

The Potential Systemic Anti-Inflammatory Effect of Turmeric Dried Extract

Author(s): Concetta Montanino*orcid of author, Federica Farinella, Bruna De Felice, Andrea Del Buono and Armando D'Orta

Volume 25, Issue 14, 2025

Published on: 08 January, 2025

Page: [1191 - 1198] Pages: 8

DOI: 10.2174/0118715303329562241116045410

open_access

Become a Editorial Board Member
Become a Reviewer
Become a Editor
Become a Section Editor

Abstract

Background: Curcumin is a polyphenolic compound derived from the food spice turmeric that has received interest from the medical and scientific world for its role in the management of several conditions. Clinical studies, in humans, have shown that ingested Curcumin is safe even at high doses (12 g/day), but it has poor bioavailability primarily due to poor absorption and rapid metabolism and elimination. Several strategies have been implemented to improve the bioavailability of Curcumin, for example, the combination of piperine in a complex with Curcumin, or the usage of formulations with phospholipid or liposomal complexes.

Objective: The present work aims to explore and compare the systemic anti-inflammatory effects of two different types of Curcumin: a traditional fat-soluble formulation (95% Curcumin) and an innovative standardized reconstituted water-soluble one (Curcuin), made in micelles in aqueous solution.

Methods: Research was conducted on 30 patients, 15 patients were treated with turmeric (Curcuma longa L., rhizome) dried extract titled 95% Curcumin (Curcumin 425mg/day) conjugated with piperine, and 15 patients were treated with Curcumin (turmeric 286 mg dried extract titled 35%; Curcuminoids 100 mg/day, standardized water-soluble) made in micelles in highly absorbed aqueous solution. We considered the quantitative variations of laboratory parameters: Erythrocyte Sedimentation Rate (ESR), C-reactive protein (CRP), Ferritin (24 to 336 ng/mL for adult males), and cholesterol LDL.

Results and Discussion: Patients treated with dried extract titled 95% Curcumin, for 90 days, show a lower value of ESR, CRP, Ferritin, and LDL cholesterol compared with the same laboratory parameters before the introduction of Curcumin into the diet. Also, patients treated with Curcuin report a lower value of ESR, CRP, Ferritin, and LDL cholesterol after the introduction of turmeric dried extract in the diet, but with a major significance compared with those obtained with 95% Curcumin conjugated with piperine.

Conclusion: As we had hypothesized, both turmeric-derived extracts have successfully reduced ESR, CRP, Ferritin, and cholesterol LDL values, exerting an anti-inflammatory action and anti-cholesterolemic action. These results suggest a possible use of Curcumin and in particular Curcuin as a coadjuvant for the treatment of inflammatory disease and to decrease cholesterol levels. However, additional investigation is needed to resolve doubts regarding Curcumin dosage form, dose, and medication frequency.

Keywords: Anti-inflammatory, cholesterol LDL, CRP, ESR, Ferritin, PCR, turmeric.

Graphical Abstract

[1]
Smirnova, E.; Moniruzzaman, M.; Chin, S.; Sureshbabu, A.; Karthikeyan, A.; Do, K.; Min, T. A review of the role of Curcumin in metal induced toxicity. Antioxidants, 2023, 12(2), 243.
[http://dx.doi.org/10.3390/antiox12020243] [PMID: 36829803]
[2]
Nelson, K.M.; Dahlin, J.L.; Bisson, J.; Graham, J.; Pauli, G.F.; Walters, M.A. The essential medicinal chemistry of Curcumin. J. Med. Chem., 2017, 60(5), 1620-1637.
[http://dx.doi.org/10.1021/acs.jmedchem.6b00975] [PMID: 28074653]
[3]
Tamegart, L.; Abbaoui, A.; Laabbar, W.; Oukhrib, M.; Bouyatas, M.M.; Gamrani, H. Study of the neurochemical alterations produced by acute and subchronic pb-exposure in meriones shawi: Immunohistochemical study of reissner’s fiber secretion by the subcommissural organ after Curcumin-III treatment. J. Trace Elem. Med. Biol., 2022, 71, 126933.
[http://dx.doi.org/10.1016/j.jtemb.2022.126933] [PMID: 35066456]
[4]
Hartogh, D.D.J.; Gabriel, A.; Tsiani, E. Antidiabetic properties of Curcumin II: Evidence from in vivo studies. Nutrients, 2019, 12(1), 58.
[http://dx.doi.org/10.3390/nu12010058] [PMID: 31881654]
[5]
Abrahams, S.; Haylett, W.L.; Johnson, G.; Carr, J.A.; Bardien, S. Antioxidant effects of Curcumin in models of neurodegeneration, aging, oxidative and nitrosative stress: A review. Neuroscience, 2019, 406, 1-21.
[http://dx.doi.org/10.1016/j.neuroscience.2019.02.020] [PMID: 30825584]
[6]
Zhang, W.; Chen, Y.; Yang, F.; Zhang, H.; Su, T.; Wang, J.; Zhang, Y.; Song, X. Antiviral effect of palmatine against infectious bronchitis virus through regulation of NF-κB/IRF7/JAK-STAT signalling pathway and apoptosis. Br. Poult. Sci., 2024, 65(2), 119-128.
[http://dx.doi.org/10.1080/00071668.2023.2296929] [PMID: 38166582]
[7]
Wang, W.; Li, M.; Wang, L.; Chen, L.; Goh, B.C. Curcumin in cancer therapy: Exploring molecular mechanisms and overcoming clinical challenges. Cancer Lett., 2023, 570, 216332.
[http://dx.doi.org/10.1016/j.canlet.2023.216332] [PMID: 37541540]
[8]
Cai, Y.; Huang, C.; Zhou, M.; Xu, S.; Xie, Y.; Gao, S.; Yang, Y.; Deng, Z.; Zhang, L.; Shu, J.; Yan, T.; Wan, C.C. Role of Curcumin in the treatment of acute kidney injury: Research challenges and opportunities. Phytomedicine, 2022, 104, 154306.
[http://dx.doi.org/10.1016/j.phymed.2022.154306] [PMID: 35809376]
[9]
Ganjali, S.; Blesso, C.N.; Banach, M.; Pirro, M.; Majeed, M.; Sahebkar, A. Effects of Curcumin on HDL functionality. Pharmacol. Res., 2017, 119, 208-218.
[http://dx.doi.org/10.1016/j.phrs.2017.02.008] [PMID: 28192240]
[10]
Reis, P.C.S.G.; Alves, A.G.P.; Guillo, L.A.; Sousa, M.A.; Trindade, N.R.; Silva, M.S. Curcumin supplementation reduces blood glucose and serum lipids of Brazilian women with high waist circumference: A randomized clinical trial. Arch. Endocrinol. Metab., 2022, 66(6), 800-807.
[http://dx.doi.org/10.20945/2359-3997000000513] [PMID: 36155119]
[11]
Radwan, A.M.; Fatoh, S.A.; Massoud, A.; Tousson, E. Effectiveness of Curcumin nanoparticles in rat liver fibrosis caused by thioacetamide. Environ. Toxicol., 2024, 39(1), 388-397.
[http://dx.doi.org/10.1002/tox.23984] [PMID: 37782692]
[12]
Jagetia, G.C.; Aggarwal, B.B. “Spicing up” of the immune system by Curcumin. J. Clin. Immunol., 2007, 27(1), 19-35.
[http://dx.doi.org/10.1007/s10875-006-9066-7] [PMID: 17211725]
[13]
Zeng, L.; Yang, T.; Yang, K.; Yu, G.; Li, J.; Xiang, W.; Chen, H. Efficacy and safety of Curcumin and Curcuma longa extract in the treatment of arthritis: A systematic review and meta-analysis of randomized controlled trial. Front. Immunol., 2022, 13, 891822.
[http://dx.doi.org/10.3389/fimmu.2022.891822] [PMID: 35935936]
[14]
Kou, H.; Huang, L.; Jin, M.; He, Q.; Zhang, R.; Ma, J. Effect of Curcumin on Rheumatoid arthritis: A systematic review and meta-analysis. Front. Immunol., 2023, 14, 1121655.
[http://dx.doi.org/10.3389/fimmu.2023.1121655] [PMID: 37325651]
[15]
Rad, S.J.; Rayess, Y.E.; Rizk, A.A.; Sadaka, C.; Zgheib, R.; Zam, W.; Sestito, S.; Rapposelli, S.; Skocińska, N.K.; Zielińska, D.; Salehi, B.; Setzer, W.N.; Dosoky, N.S.; Taheri, Y.; Beyrouthy, E.M.; Martorell, M.; Ostrander, E.A.; Suleria, H.A.R.; Cho, W.C.; Maroyi, A.; Martins, N. Turmeric and its major compound Curcumin on health: Bioactive effects and safety profiles for food, pharmaceutical, biotechnological and medicinal applications. Front. Pharmacol., 2020, 11, 01021.
[http://dx.doi.org/10.3389/fphar.2020.01021] [PMID: 33041781]
[16]
Panknin, T.M.; Howe, C.L.; Hauer, M.; Bucchireddigari, B.; Rossi, A.M.; Funk, J.L. Curcumin supplementation and human disease: A scoping review of clinical trials. Int. J. Mol. Sci., 2023, 24(5), 4476.
[http://dx.doi.org/10.3390/ijms24054476] [PMID: 36901908]
[17]
Bhat, A.; Mahalakshmi, A.M.; Ray, B.; Tuladhar, S.; Hediyal, T.A.; Manthiannem, E.; Padamati, J.; Chandra, R.; Chidambaram, S.B.; Sakharkar, M.K. Benefits of Curcumin in brain disorders. Biofactors, 2019, 45(5), 666-689.
[http://dx.doi.org/10.1002/biof.1533] [PMID: 31185140]
[18]
Sadeghi, M.; Dehnavi, S.; Asadirad, A.; Xu, S.; Majeed, M.; Jamialahmadi, T.; Johnston, T.P.; Sahebkar, A. Curcumin and chemokines: Mechanism of action and therapeutic potential in inflammatory diseases. Inflammopharmacol., 2023, 31(3), 1069-1093.
[http://dx.doi.org/10.1007/s10787-023-01136-w] [PMID: 36997729]
[19]
Hasanzadeh, S.; Read, M.I.; Bland, A.R.; Majeed, M.; Jamialahmadi, T.; Sahebkar, A. Curcumin: An inflammasome silencer. Pharmacol. Res., 2020, 159, 104921.
[http://dx.doi.org/10.1016/j.phrs.2020.104921] [PMID: 32464325]
[20]
Lin, X.; Bai, D.; Wei, Z.; Zhang, Y.; Huang, Y.; Deng, H.; Huang, X. Curcumin attenuates oxidative stress in RAW264.7 cells by increasing the activity of antioxidant enzymes and activating the Nrf2-Keap1 pathway. PLoS One, 2019, 14(5), e0216711.
[http://dx.doi.org/10.1371/journal.pone.0216711] [PMID: 31112588]
[21]
Vallée, A.; Lecarpentier, Y.; Vallée, J.N. Curcumin: A therapeutic strategy in cancers by inhibiting the canonical WNT/β-catenin pathway. J. Exp. Clin. Cancer Res., 2019, 38(1), 323.
[http://dx.doi.org/10.1186/s13046-019-1320-y] [PMID: 31331376]
[22]
Sathyabhama, M.; Dharshini, P.L.C.; Karthikeyan, A.; Kalaiselvi, S.; Min, T. The credible role of Curcumin in oxidative stress-mediated mitochondrial dysfunction in mammals. Biomolecules, 2022, 12(10), 1405.
[http://dx.doi.org/10.3390/biom12101405] [PMID: 36291614]
[23]
Khalili, F.A.; Ostadrahimi, A.; Mirghafourvand, M.; Almanghadim, A.K.; Dousti, S.; Iranshahi, A.M. Clinical efficacy of Curcumin and vitamin E on inflammatory-oxidative stress biomarkers and primary symptoms of menopause in healthy postmenopausal women: A triple-blind randomized controlled trial. J. Nutr. Metab., 2022, 2022, 1-12.
[http://dx.doi.org/10.1155/2022/6339715] [PMID: 35719707]
[24]
Esmaealzadeh, N.; Miri, M.S.; Mavaddat, H.; Peyrovinasab, A.; Zargar, G.S.; Kabiri, S.S.; Razavi, S.M.; Abdolghaffari, A.H. The regulating effect of Curcumin on NF-κB pathway in neurodegenerative diseases: A review of the underlying mechanisms. Inflammopharmacol., 2024, 32(4), 2125-2151.
[http://dx.doi.org/10.1007/s10787-024-01492-1] [PMID: 38769198]
[25]
Reuter, S.; Gupta, S.C.; Park, B.; Goel, A.; Aggarwal, B.B. Epigenetic changes induced by Curcumin and other natural compounds. Genes Nutr., 2011, 6(2), 93-108.
[http://dx.doi.org/10.1007/s12263-011-0222-1] [PMID: 21516481]
[26]
Boyanapalli, S.S.S.; Kong, A.N.T. “Curcumin, the king of spices”: Epigenetic regulatory mechanisms in the prevention of cancer, neurological, and inflammatory diseases. Curr. Pharmacol. Rep., 2015, 1(2), 129-139.
[http://dx.doi.org/10.1007/s40495-015-0018-x] [PMID: 26457241]
[27]
Abdelaziz, N.; Therachiyil, L.; Sadida, H.Q.; Ali, A.M.; Khan, O.S.; Singh, M.; Khan, A.Q.; Akil, A.S.A.S.; Bhat, A.A.; Uddin, S. Epigenetic inhibitors and their role in cancer therapy. Int. Rev. Cell Mol. Biol., 2023, 380, 211-251.
[http://dx.doi.org/10.1016/bs.ircmb.2023.04.005] [PMID: 37657859]
[28]
Hassan, F.; Rehman, M.S.; Khan, M.S.; Ali, M.A.; Javed, A.; Nawaz, A.; Yang, C. Curcumin as an alternative epigenetic modulator: Mechanism of action and potential effects. Front. Genet., 2019, 10, 514.
[http://dx.doi.org/10.3389/fgene.2019.00514] [PMID: 31214247]
[29]
Anand, P.; Kunnumakkara, A.B.; Newman, R.A.; Aggarwal, B.B. Bioavailability of Curcumin: Problems and promises. Mol. Pharm., 2007, 4(6), 807-818.
[http://dx.doi.org/10.1021/mp700113r] [PMID: 17999464]
[30]
Cas, D.M.; Ghidoni, R. Dietary Curcumin: Correlation between bioavailability and health potential. Nutrients, 2019, 11(9), 2147.
[http://dx.doi.org/10.3390/nu11092147] [PMID: 31500361]
[31]
Heidari, H.; Bagherniya, M.; Majeed, M.; Sathyapalan, T.; Jamialahmadi, T.; Sahebkar, A. Curcumin-piperine co-supplementation and human health: A comprehensive review of preclinical and clinical studies. Phytother. Res., 2023, 37(4), 1462-1487.
[http://dx.doi.org/10.1002/ptr.7737] [PMID: 36720711]
[32]
Hewlings, S.; Kalman, D. Curcumin: A review of its effects on human health. Foods, 2017, 6(10), 92.
[http://dx.doi.org/10.3390/foods6100092] [PMID: 29065496]
[33]
Ueda, N.; Takasawa, K. Impact of inflammation on ferritin, hepcidin and the management of iron deficiency anemia in chronic kidney disease. Nutrients, 2018, 10(9), 1173.
[http://dx.doi.org/10.3390/nu10091173] [PMID: 30150549]
[34]
Bray, C.; Bell, L.N.; Liang, H.; Haykal, R.; Kaiksow, F.; Mazza, J.J.; Yale, S.H. Erythrocyte sedimentation rate and C-reactive protein measurements and their relevance in clinical medicine. WMJ, 2016, 115(6), 317-321.
[PMID: 29094869]
[35]
Litao, M.K.S.; Kamat, D. Erythrocyte sedimentation rate and C-reactive protein: How best to use them in clinical practice. Pediatr. Ann., 2014, 43(10), 417-420.
[http://dx.doi.org/10.3928/00904481-20140924-10] [PMID: 25290132]
[36]
Bohula, E.A.; Giugliano, R.P.; Leiter, L.A.; Verma, S.; Park, J.G.; Sever, P.S.; Pineda, L.A.; Honarpour, N.; Wang, H.; Murphy, S.A.; Keech, A.; Pedersen, T.R.; Sabatine, M.S. Inflammatory and cholesterol risk in the fourier trial. Circulation, 2018, 138(2), 131-140.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.118.034032] [PMID: 29530884]
[37]
Kroon, M.A.G.M.; Laarhoven, V.H.W.M.; Swart, E.L.; Kemper, E.M.; Tellingen, V.O. A validated HPLC-MS/MS method for simultaneously analyzing Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetra-hydrocurcumin and piperine in human plasma, urine or feces. Heliyon, 2023, 9(5), e15540.
[http://dx.doi.org/10.1016/j.heliyon.2023.e15540] [PMID: 37131436]
[38]
Gupta, S.C.; Patchva, S.; Aggarwal, B.B. Therapeutic roles of Curcumin: Lessons learned from clinical trials. AAPS J., 2013, 15(1), 195-218.
[http://dx.doi.org/10.1208/s12248-012-9432-8] [PMID: 23143785]
[39]
Liu, W.; Zhai, Y.; Heng, X.; Che, F.Y.; Chen, W.; Sun, D.; Zhai, G. Oral bioavailability of Curcumin: Problems and advancements. J. Drug Target., 2016, 24(8), 694-702.
[http://dx.doi.org/10.3109/1061186X.2016.1157883] [PMID: 26942997]
[40]
Racz, L.Z.; Racz, C.P.; Pop, L.C.; Tomoaia, G.; Mocanu, A.; Barbu, I.; Sárközi, M.; Roman, I.; Avram, A.; Cotisel, T.M.; Toma, V.A. Strategies for improving bioavailability, bioactivity, and physical-chemical behavior of Curcumin. Molecules, 2022, 27(20), 6854.
[http://dx.doi.org/10.3390/molecules27206854] [PMID: 36296447]
[41]
Ipar, V.S.; Dsouza, A.; Devarajan, P.V. Enhancing Curcumin oral bioavailability through nanoformulations. Eur. J. Drug Metab. Pharmacokinet., 2019, 44(4), 459-480.
[http://dx.doi.org/10.1007/s13318-019-00545-z] [PMID: 30771095]
[42]
Shoba, G.; Joy, D.; Joseph, T.; Majeed, M.; Rajendran, R.; Srinivas, P. Influence of piperine on the pharmacokinetics of Curcumin in animals and human volunteers. Planta Med., 1998, 64(4), 353-356.
[http://dx.doi.org/10.1055/s-2006-957450] [PMID: 9619120]
[43]
Metzler, M.; Pfeiffer, E.; Schulz, S.I.; Dempe, J.S. Curcumin uptake and metabolism. Biofactors, 2013, 39(1), 14-20.
[http://dx.doi.org/10.1002/biof.1042] [PMID: 22996406]
[44]
Wang, Y.; Li, Y.; He, L.; Mao, B.; Chen, S.; Martinez, V.; Guo, X.; Shen, X.; Liu, B.; Li, C. Commensal flora triggered target anti-inflammation of alginate-curcumin micelle for ulcerative colitis treatment. Colloids Surf. B Biointerfaces, 2021, 203, 111756.
[http://dx.doi.org/10.1016/j.colsurfb.2021.111756] [PMID: 33865087]
[45]
Han, J.; Oh, J.; Ihm, S.H.; Lee, M. Peptide micelle-mediated Curcumin delivery for protection of islet β-cells under hypoxia. J. Drug Target., 2016, 24(7), 618-623.
[http://dx.doi.org/10.3109/1061186X.2015.1132220] [PMID: 26768151]
[46]
Zhang, Z.; Zhang, X. Curcumin loading on alginate nano-micelle for anti-infection and colonic wound healing. J. Biomed. Nanotechnol., 2021, 17(6), 1160-1169.
[http://dx.doi.org/10.1166/jbn.2021.3089] [PMID: 34167629]
[47]
Huang, L.; Huang, X.H.; Yang, X.; Hu, J.Q.; Zhu, Y.Z.; Yan, P.Y.; Xie, Y. Novel nano-drug delivery system for natural products and their application. Pharmacol. Res., 2024, 201, 107100.
[http://dx.doi.org/10.1016/j.phrs.2024.107100] [PMID: 38341055]
[48]
Furman, D.; Campisi, J.; Verdin, E.; Bastos, C.P.; Targ, S.; Franceschi, C.; Ferrucci, L.; Gilroy, D.W.; Fasano, A.; Miller, G.W.; Miller, A.H.; Mantovani, A.; Weyand, C.M.; Barzilai, N.; Goronzy, J.J.; Rando, T.A.; Effros, R.B.; Lucia, A.; Kleinstreuer, N.; Slavich, G.M. Chronic inflammation in the etiology of disease across the life span. Nat. Med., 2019, 25(12), 1822-1832.
[http://dx.doi.org/10.1038/s41591-019-0675-0] [PMID: 31806905]